Gilead Sciences Inc (GILD)
Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow GILD in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on GILD and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
GILD at a glance
Key statistics
$194.07B
Market capitalization
- Previous close
- $156.51
- Open
- $155.31
- Day range
- $151.80 – $155.37
- Volume
- 3.06M
- Average volume (30 sessions)
- 5.93M
- Shares outstanding
- 1.24B
- Earnings per share
- $(2.61)
- Price / book
- 16.4
- Price / sales
- 6.4
- Dividend yield
- 2.10%
- Beta (1 year, vs SPY)
- 0.33
Where the price sits in its year
52-week range
85% of the range
- Below the 52-week high
- -4.5%
- Above the 52-week low
- +34.5%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $150.29+4.1%
- 50-day average
- $147.70+6.0%
- 200-day average
- $138.35+13.1%
Between the conventional 30 and 70 bands.
+5.8%
1 week
+4.0%
1 month
+20.1%
3 months
+27.5%
Year to date
+27.4%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with GILD
GILD on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on GILD.
See the plans →
Every planScreen names like GILD
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on GILD
Put GILD on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on GILD
See whether there is an open premium alert on GILD, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
GILD headlines
SEC Form 4, most recent first
Insider filings
Mercier Johanna
−3.0K
Chief Comm & Corp Aff Officer · Open-market sale
$468.66K · Oct 15, 2026
Dickinson Andrew D
−3.0K
Chief Financial Officer · Open-market sale
$468.66K · Oct 15, 2026
O'Day Daniel Patrick
−12.0K
Chairman & CEO, Director · Open-market sale
$1.77M · Oct 1, 2026
O'Day Daniel Patrick
−3.0K
Chairman & CEO, Director · Open-market sale
$445.88K · Oct 1, 2026
Burkhart Erin
−2.2K
SVP, Controllership · Option exercise
· Sep 22, 2026
Burkhart Erin
+2.2K
SVP, Controllership · Option exercise
· Sep 22, 2026
Burkhart Erin
−768
SVP, Controllership · Shares withheld for tax
$117.25K · Sep 22, 2026
Mercier Johanna
−600
Chief Comm & Corp Aff Officer · Open-market sale
$87.17K · Sep 15, 2026
About Gilead Sciences Inc
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Biological Products, (no Diagnostic Substances)
- Headquarters
- Foster City, CA
- Employees
- 17,000
- Listed since
- Jan 22, 1992
- Website
- gilead.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.